Cargando…
Germline sequence analysis of RABL3 in a large series of pancreatic ductal adenocarcinoma patients reveals no evidence of deleterious variants
Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with a 5‐year survival rate of less than 10%. Individuals with a pathogenic germline variant in a pancreatic cancer susceptibility gene are at an increased risk of developing pancreatic cancer. Understanding the inherited genetic basis of p...
Autores principales: | Roberts, Nicholas J., Grant, Robert C., Gallinger, Steven, Klein, Alison P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251898/ https://www.ncbi.nlm.nih.gov/pubmed/33724601 http://dx.doi.org/10.1002/gcc.22947 |
Ejemplares similares
-
Advances in the management of pancreatic ductal adenocarcinoma
por: O’Kane, Grainne M., et al.
Publicado: (2021) -
Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma
por: Ryu, Kum Hei, et al.
Publicado: (2023) -
Rare deleterious germline variants and risk of lung cancer
por: Liu, Yanhong, et al.
Publicado: (2021) -
Diagnostic rate of germline pathogenic variants in pancreatic ductal adenocarcinoma patients using whole genome sequencing
por: Chung, An-Ko, et al.
Publicado: (2023) -
CNN-based survival model for pancreatic ductal adenocarcinoma in medical imaging
por: Zhang, Yucheng, et al.
Publicado: (2020)